Discordant effect of aspirin and indomethacin on intestinal tumor burden in Apc(Min/+) mice

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 62, Issue 5, 2000, Pages 269-275

  Chiu, C H ^a   McEntee, M F ^b   Whelan, J ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; PROSTAGLANDIN INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CHEMOPROPHYLAXIS; COLON POLYPOSIS; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; INTESTINE TUMOR; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

EID: 0033915996     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2000.0154     Document Type: Article

References (41)

1. Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase?
2. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis
3. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis
4. Chemoprevention of spontaneous intestinal adenomas in the Apc(Min) mouse model by the nonsteroidal anti-inflammatory drug piroxicam
5. Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination
6. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats
7. A hypothesis: Nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer
8. Aspirin use and reduced risk of fatal colon cancer
9. Sulindac for polyposis of the colon
10. Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: Evaluation of predictive factors
11. Chemoprevention of intestinal adenomas in the Apc(Min) mouse by piroxicam: Kinetics, strain effects and resistance to chemosuppression
12. Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin
13. Aspirin prevents tumors in a murine model of familial adenomatous polyposis
14. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis
15. Protein determinations in membrane and lipoprotein samples: Manual and automated procedures
16. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs
17. Aspirin use and potential mechanisms for colorectal cancer prevention
18. Non steroidal anti-inflammatory drugs and colorectal cancer: Is there a way forward?
19. Low-dose aspirin and incidence of colorectal tumors in a randomized trial
20. Aspirin use and chronic diseases: A cohort study of the elderly (see comments)
21. Aspirin use and colorectal cancer: Post-trial follow-up data from the Physicians' Health Study
22. Intestinal tumorigenesis in the Apc1638N mouse treated with aspirin and resistant starch for up to 5 months
23. Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: Lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse
24. Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines
25. Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder
26. Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts
27. Relationship of β-catenin and Bc1-2 expression to sulindac induced regression of intestinal tumors in Min mice
28. Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis
29. Sulindac inhibits colorectal tumor growth, but not prostaglandin synthesis in the rat
30. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis
31. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase
32. Suppression of inducible cyclooxygenase-2 gene transcription by aspirin and sodium salicylate
33. Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma
34. Cyclooxygenase in biology and disease
35. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway
36. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis
37. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction
38. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels
39. Suppression of intestinal polyp development by nimesulide, a selective cyclooxygenase-2 inhibitor, in Min mice
40. 716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
41. Cyclooxygenase knockout mice: Models for elucidating isoform-specific functions